Frankfurt - Delayed Quote EUR

Bio-Gate AG (BIG1.F)

Compare
0.7000 +0.0150 (+2.19%)
At close: 5:20 PM GMT+1
Loading Chart for BIG1.F
DELL
  • Previous Close 0.6850
  • Open 0.6700
  • Bid --
  • Ask --
  • Day's Range 0.6700 - 0.7000
  • 52 Week Range 0.5750 - 1.3800
  • Volume 1,060
  • Avg. Volume 171
  • Market Cap (intraday) 6.471M
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2200
  • Earnings Date Sep 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company's products are used in large and medium-sized medical technology companies, pharmaceutical distributors, distribution companies, industrial companies, public sector companies, and hygiene-sensitive institutions. The company was founded in 2005 and is based in Nuremberg, Germany.

www.bio-gate.de

45

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIG1.F

View More

Performance Overview: BIG1.F

Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIG1.F
33.96%
DAX P
15.19%

1-Year Return

BIG1.F
25.53%
DAX P
20.38%

3-Year Return

BIG1.F
82.50%
DAX P
21.22%

5-Year Return

BIG1.F
53.64%
DAX P
45.67%

Compare To: BIG1.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIG1.F

View More

Valuation Measures

Annual
As of 11/25/2024
  • Market Cap

    6.24M

  • Enterprise Value

    5.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.84

  • Price/Book (mrq)

    2.76

  • Enterprise Value/Revenue

    0.76

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -26.32%

  • Return on Assets (ttm)

    -25.82%

  • Return on Equity (ttm)

    -68.91%

  • Revenue (ttm)

    7.61M

  • Net Income Avi to Common (ttm)

    -2M

  • Diluted EPS (ttm)

    -0.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    476k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -169.26k

Research Analysis: BIG1.F

View More

Company Insights: BIG1.F

Research Reports: BIG1.F

View More